Cultivamente

1 paper3 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Human trial1

Outcomes

Cognitive impairment

downin humans1

1 study

Cultivamente decreases cognitive impairment in humans.
“and a lower prevalence of mild-to-moderate cognitive impairment”
Human trialcognitive impairment but no dementia6 months
A Nudge-Based Campaign for Dementia Prevention Outcomes: A Pragmatic Cluster-Randomized Trial
GSA 2025 abstract31 Dec 2025

Latest

1 in 12 months

GSA 2025 Abstract3 Jan

A Nudge-Based Campaign for Dementia Prevention Outcomes: A Pragmatic Cluster-Randomized Trial

Randomised trial in peopleDementia

Paper

Cultivamente

Outcomes

Latest

A Nudge-Based Campaign for Dementia Prevention Outcomes: A Pragmatic Cluster-Randomized Trial

Related